Effect of diclofenac as a prophylactic analgesic during hysterosalpingography in Bayelsa State, South-South Nigeria: a randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Fertility-female
- Registration Number
- PACTR202203544008183
- Lead Sponsor
- Dr. Peter Chibuzor Oriji
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 380
Inclusion Criteria
Infertile women referred for hysterosalpingography, and women that gave consent and completely filled the consent/questionnaire form will be included in the study
Exclusion Criteria
Exclusion criteria included abnormal uterine/vaginal bleeding before the procedure, on-going menstruation, pregnancy, discharge on inspection of the cervix, cervical stenosis/cervical pathology, evidence of pelvic inflammatory disease, previous history of contrast hypersensitivity, history of allergy to diclofenac, and all patients that declined consent or incompletely filled the consent form and questionnaire.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcomes include pain scores during and immediately after the procedure.
- Secondary Outcome Measures
Name Time Method The secondary outcomes include differences in pain scores, and presence of any adverse effect in any of the groups.